- $831.31m
- $638.99m
- $692.52m
EverQuote Inc reports results for the quarter ended June 30 - Earnings Summary
EverQuote Q2 revenue beats estimates on auto, home insurance demand
Brief: EverQuote Q2 Revenue USD 195.086 Million Vs. IBES Estimate USD 190.4 Million
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
EverQuote's Q1 revenue beats analyst estimates on strong home, renters insurance sales
Brief: EverQuote Q1 Revenue USD 190.852 Million Vs. IBES Estimate USD 180.2 Million
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies
EverQuote Q4 revenue beats estimates
Brief: EverQuote Q4 Revenue USD 195.32 Million Vs. IBES Estimate USD 176.8 Million
U.S. RESEARCH ROUNDUP-Affiliated Managers Group, Argenx SE, Cardinal Health Inc
EverQuote Q3 revenue beats expectations helped by strong showing in automotive insurance vertical
U.S. RESEARCH ROUNDUP- Axon Enterprise, Berkshire Hathaway, Idexx Laboratories
EverQuote Inc reports results for the quarter ended June 30 - Earnings Summary
EverQuote's Q2 revenue grows 34% but misses estimates
EverQuote Inc reports results for the quarter ended March 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Maze Therapeutics, UFP Technologies, Itron
U.S. STOCKS ON THE MOVE-AxoGen, Portillo, Cisco Systems
U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPal
U.S. STOCKS ON THE MOVE- Zoom Communications, Home Depot, Civitas Resources